FINWIRES · TerminalLIVE
FINWIRES

GSK's Efimosfermin Receives FDA, EMA Designations for MASH

By

GSK (GSK) said Monday its liver therapy efimosfermin received Breakthrough Therapy Designation from the US Food and Drug Administration and Priority Medicines designation from the European Medicines Agency for the treatment of metabolic dysfunction-associated steatohepatitis, or MASH.

The FDA designation is intended to expedite the development and review of medicines, while the EMA designation provides scientific and regulatory support.

The designations were supported by phase 2 data in patients with moderate to advanced and cirrhotic fibrosis, which showed improvement in liver fibrosis and MASH resolution versus placebo. The company said the therapy demonstrated a generally well-tolerated safety profile.

Phase 3 trials in MASH patients with cirrhotic fibrosis are expected to start this year, the company said.

Price: $54.48, Change: $+0.04, Percent Change: +0.06%

Related Articles

Wire

Brazilian Rare Earths Targets Brazil Critical Minerals Province Scoping Study, Mineral Resource Estimate for Mid-2026; Shares Up 4%

Brazilian Rare Earths (ASX:BRE) said that the mineral resource estimate and scoping study for the Rocha da Rocha critical minerals province are both targeted for mid-2026, according to a Monday Australian bourse filing.Sensor-based ore sorting testing validated a simple, dry beneficiation pathway for the Monte Alto project, while a metallurgical optimization program validated low-temperature acid-cure processing at 150 degrees celsius, with a 15 kilograms blended composite scale-up test confirming high extraction performance and strong scalability, the filing said.The company expects to submit an economic development plan for the project to Brazil's National Mining Agency in the June quarter.Brazilian Rare Earths' shares rose nearly 4% in recent trading on Monday.

ASX:BRE
Wire

Sector Update: Energy Stocks Softer Late Afternoon

Energy stocks declined late Friday afternoon, with the NYSE Energy Sector Index shedding 0.7% and the State Street Energy Select Sector SPDR ETF (XLE) decreasing 0.2%.The Philadelphia Oil Service Sector Index rose 1.8%, and the Dow Jones US Utilities Index added 0.1%.West Texas Intermediate crude oil fell 1.2% to $94.68 a barrel, and global benchmark Brent rose 0.5% to $105.64 a barrel. Henry Hub natural gas futures shed 3.7% to $2.52 per 1 million BTU.In corporate news, TotalEnergies (TTE) secured financing for its Mirny onshore wind and battery energy storage system project in southeast Kazakhstan. The stock fell 0.7%.X-Energy (XE) shares jumped 27% following their debut on Nasdaq.SLB (SLB) reported mixed Q1 results, reflecting headwinds from the Middle East conflict. The shares rose 2.8% as revenue topped estimates, while earnings fell.BP (BP) and Repsol have been accused of anti-competitive practices in a complaint filed with the European Commission by Spanish fuel wholesaler Hatta Energy, Bloomberg reported. BP shares were down 0.4%.

$BP$SLB$TTE$XE
Wire

Sector Update: Energy

Energy stocks declined late Friday afternoon with the NYSE Energy Sector Index shedding 0.7% and the State Street Energy Select Sector SPDR ETF (XLE) decreasing 0.4%.The Philadelphia Oil Service Sector Index rose 1.8%, and the Dow Jones US Utilities Index was little changed.West Texas Intermediate crude oil fell 1.1% to $94.79 a barrel, and global benchmark Brent rose 0.8% to $105.87 a barrel. Henry Hub natural gas futures shed 3.8% to $2.52 per 1 million BTU.In corporate news, TotalEnergies (TTE) secured financing for its Mirny onshore wind and battery energy storage system project in southeast Kazakhstan. The stock fell 0.7%.

$TTE